Waters Revenue 2010-2025 | WAT
Waters annual/quarterly revenue history and growth rate from 2010 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Waters revenue for the quarter ending March 31, 2025 was $0.662B, a 3.9% increase year-over-year.
- Waters revenue for the twelve months ending March 31, 2025 was $2.983B, a 2.57% increase year-over-year.
- Waters annual revenue for 2024 was $2.958B, a 0.07% increase from 2023.
- Waters annual revenue for 2023 was $2.956B, a 0.52% decline from 2022.
- Waters annual revenue for 2022 was $2.972B, a 6.68% increase from 2021.
| Waters Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $2,958 |
| 2023 | $2,956 |
| 2022 | $2,972 |
| 2021 | $2,786 |
| 2020 | $2,365 |
| 2019 | $2,407 |
| 2018 | $2,420 |
| 2017 | $2,309 |
| 2016 | $2,167 |
| 2015 | $2,042 |
| 2014 | $1,989 |
| 2013 | $1,904 |
| 2012 | $1,844 |
| 2011 | $1,851 |
| 2010 | $1,643 |
| 2009 | $1,499 |
| Waters Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-03-31 | $662 |
| 2024-12-31 | $873 |
| 2024-09-30 | $740 |
| 2024-06-30 | $709 |
| 2024-03-31 | $637 |
| 2023-12-31 | $819 |
| 2023-09-30 | $712 |
| 2023-06-30 | $741 |
| 2023-03-31 | $685 |
| 2022-12-31 | $859 |
| 2022-09-30 | $709 |
| 2022-06-30 | $714 |
| 2022-03-31 | $691 |
| 2021-12-31 | $836 |
| 2021-09-30 | $659 |
| 2021-06-30 | $682 |
| 2021-03-31 | $609 |
| 2020-12-31 | $787 |
| 2020-09-30 | $594 |
| 2020-06-30 | $520 |
| 2020-03-31 | $465 |
| 2019-12-31 | $716 |
| 2019-09-30 | $577 |
| 2019-06-30 | $599 |
| 2019-03-31 | $514 |
| 2018-12-31 | $715 |
| 2018-09-30 | $578 |
| 2018-06-30 | $596 |
| 2018-03-31 | $531 |
| 2017-12-31 | $687 |
| 2017-09-30 | $566 |
| 2017-06-30 | $558 |
| 2017-03-31 | $498 |
| 2016-12-31 | $629 |
| 2016-09-30 | $527 |
| 2016-06-30 | $537 |
| 2016-03-31 | $475 |
| 2015-12-31 | $587 |
| 2015-09-30 | $501 |
| 2015-06-30 | $495 |
| 2015-03-31 | $460 |
| 2014-12-31 | $584 |
| 2014-09-30 | $493 |
| 2014-06-30 | $482 |
| 2014-03-31 | $431 |
| 2013-12-31 | $565 |
| 2013-09-30 | $457 |
| 2013-06-30 | $451 |
| 2013-03-31 | $430 |
| 2012-12-31 | $522 |
| 2012-09-30 | $450 |
| 2012-06-30 | $451 |
| 2012-03-31 | $420 |
| 2011-12-31 | $521 |
| 2011-09-30 | $455 |
| 2011-06-30 | $448 |
| 2011-03-31 | $428 |
| 2010-12-31 | $484 |
| 2010-09-30 | $401 |
| 2010-06-30 | $391 |
| 2010-03-31 | $368 |
| 2009-12-31 | $429 |
| 2009-09-30 | $374 |
| 2009-06-30 | $363 |
| 2009-03-31 | $333 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $20.792B | $2.958B |
| Waters Corp. is an analytical instrument manufacturer and offers practical and sustainable products for laboratory-dependent organizations. Moreover, Waters provides analytical workflow solutions based on mass spectrometry (MS), liquid chromatography (LC) and thermal analysis technologies. The company's products are used by pharmaceutical, life science, biochemical, industrial, academic and government customers, working in research and development, quality assurance and other laboratory applications. The company operates in Asia, Americas and Europe. Waters organizes its business into two operating segments: Waters Division and TA Division. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $197.793B | 86.63 |
| Thermo Fisher Scientific (TMO) | United States | $150.971B | 18.26 |
| Edwards Lifesciences (EW) | United States | $45.591B | 29.89 |
| IDEXX Laboratories (IDXX) | United States | $42.288B | 48.60 |
| Alcon (ALC) | Switzerland | $42.138B | 28.48 |
| DexCom (DXCM) | United States | $34.031B | 52.60 |
| IQVIA Holdings (IQV) | United States | $24.701B | 13.84 |
| Mettler-Toledo (MTD) | United States | $24.242B | 28.83 |
| STERIS (STE) | Ireland | $23.937B | 26.36 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.231B | 0.00 |
| Hologic (HOLX) | United States | $14.048B | 15.26 |
| Sysmex ADR (SSMXY) | Japan | $10.336B | 29.32 |
| Penumbra (PEN) | United States | $9.967B | 78.22 |
| Masimo (MASI) | United States | $8.883B | 32.77 |
| Globus Medical (GMED) | United States | $8.082B | 19.26 |
| Glaukos (GKOS) | United States | $5.399B | 0.00 |
| Teleflex (TFX) | United States | $5.366B | 8.86 |
| TransMedics (TMDX) | United States | $4.355B | 94.66 |
| Integer Holdings (ITGR) | United States | $4.182B | 21.91 |
| PROCEPT BioRobotics (PRCT) | United States | $3.319B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.405B | 14.32 |
| Veracyte (VCYT) | United States | $2.075B | 29.12 |
| Nihon Kohden (NHNKY) | Japan | $2.022B | 23.20 |
| Elekta AB (EKTAY) | Sweden | $1.956B | 17.59 |
| Alphatec Holdings (ATEC) | United States | $1.851B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.374B | 0.00 |
| Artivion (AORT) | United States | $1.215B | 113.80 |
| Pulse Biosciences (PLSE) | United States | $1.186B | 0.00 |
| OPKO Health (OPK) | United States | $1.094B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.013B | 5.39 |
| SiBone (SIBN) | United States | $0.805B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.779B | 0.00 |
| IRadimed (IRMD) | United States | $0.760B | 38.57 |
| RxSight (RXST) | United States | $0.642B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.576B | 8.96 |
| Delcath Systems (DCTH) | United States | $0.560B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.546B | 12.80 |
| AxoGen (AXGN) | United States | $0.517B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.496B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.445B | 0.00 |
| NeuroPace (NPCE) | United States | $0.444B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.432B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.397B | 10.56 |
| Treace Medical Concepts (TMCI) | United States | $0.365B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.354B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.315B | 0.00 |
| Neuronetics (STIM) | United States | $0.254B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.239B | 14.48 |
| 908 Devices (MASS) | United States | $0.237B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.211B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.208B | 0.00 |
| CVRx (CVRX) | United States | $0.176B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.175B | 0.00 |
| Inogen (INGN) | United States | $0.172B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.171B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.163B | 0.00 |
| Accuray (ARAY) | United States | $0.162B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.161B | 0.00 |
| LENSAR (LNSR) | United States | $0.160B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.136B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.110B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.099B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.087B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.079B | 48.30 |
| InspireMD (NSPR) | United States | $0.078B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.067B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.061B | 0.00 |
| Hyperfine (HYPR) | United States | $0.058B | 0.00 |
| Positron (POSC) | United States | $0.054B | 0.00 |
| Spectral AI (MDAI) | United States | $0.044B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.043B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Envoy Medical (COCH) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.028B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.012B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.19 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |